Duchenne Muscular Dystrophy Clinical Trials in London, Ontario
5 recruitingLondon, Ontario, Canada
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
A Phase 1/2 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMN 351 in Participants With Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy
BioMarin Pharmaceutical18 enrolled8 locationsNCT06280209
Recruiting
Phase 2
NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)
Duchenne Muscular DystrophyDMDExon 44
NS Pharma, Inc.20 enrolled25 locationsNCT05996003
Recruiting
Phase 2Phase 3
AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)
Duchenne Muscular Dystrophy
REGENXBIO Inc.65 enrolled17 locationsNCT05693142
Recruiting
Phase 1Phase 2
NS-050/NCNP-03 in Boys With DMD (Meteor50)
Duchenne Muscular Dystrophy
NS Pharma, Inc.20 enrolled18 locationsNCT06053814
Recruiting
Phase 3
Efficacy, Safety and Tolerability of Givinostat in Non-ambulant Patients With Duchenne Muscular Dystrophy
Duchenne Muscular Dystrophy
Italfarmaco138 enrolled20 locationsNCT05933057